{
    "organizations": [],
    "uuid": "b560877ecb902802d617b52677b82d1eb5893f73",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biohitech-global-approved-for-nasd/brief-biohitech-global-approved-for-nasdaq-listing-idUSFWN1RJ0BW",
    "ord_in_thread": 0,
    "title": "BRIEF-BioHiTech Global Approved For Nasdaq Listing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 6 (Reuters) - BioHiTech Global Inc:\n* BIOHITECH GLOBAL, INC. APPROVED FOR NASDAQ LISTING * ANTICIPATED THAT BIOHITECHâ€™S COMMON STOCK WILL COMMENCE TRADING ON NASDAQ CAPITAL MARKET ON APRIL 9 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-06T20:50:00.000+03:00",
    "crawled": "2018-04-07T16:19:08.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "biohitech",
        "global",
        "inc",
        "biohitech",
        "global",
        "approved",
        "nasdaq",
        "listing",
        "anticipated",
        "biohitech",
        "common",
        "stock",
        "commence",
        "trading",
        "nasdaq",
        "capital",
        "market",
        "april",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}